BioSpace News Archive

the co-chairs of the federal, provincial and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses—Dr. Theresa Tam, Canada’s Chief Public Health Officer and Dr. Jennifer Russell, New Brunswick’s Chief Medical Officer of Health—issued the following statement on the release of updated data on opioid-related harms in Canada, covering the period of January 1, 2016 to June 30, 2020.

SHINE Medical Technologies LLC announced that the company has broken ground on a new 54,000-square-foot facility that will house its corporate headquarters and a large-scale production facility for the Therapeutics division it established last year.

FDA Granted Breakthrough Therapy Designation for Sotorasib Sotorasib Application Being Reviewed Under FDA Real-Time Oncology Review (RTOR) Pilot Program

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 11, 2021 at 9:10 a.m. Eastern Time. The live webcast of Baxter’s presentation, along with accompanying slides, can be accessed at www.baxter.com

MARGENZA (margetuximab-cmkb) is the first HER2-targeted therapy to have improved progression-free survival (PFS) versus Herceptin® ( trastuzumab), both combined with chemotherapy, in a head-to-head Phase 3 clinical trial MARGENZA is approved, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the first quarter of 2021. The dividend will be paid on March 8, 2021 , to all stockholders of record as of the close of business on February 15 , 2021. This represents a 10% increase from that paid in each of the pre

Administration of neflamapimod during the subacute phase after transient ischemia induced stroke in rats promoted functional recovery Associated increased levels of brain-derived neurotrophic factor (BDNF) suggest the effects were mediated by increasing synaptic plasticity

Briotech, Inc. announced a distribution agreement with Intermodeco 2004 SRL, for the country of Romania . Intermodeco will begin distribution of imported Briotech Pure Hypochlorous (HOCl)

Virios Therapeutics, Inc. (the “Company”), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $30 million, before deducting underwriting discounts, commissions and o

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an Advance Purchase Agreement with the government of New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, Novavax’ candidate vaccine against COVID-19. Currently in Phase 3 clinical testing in the United Kingdom for the prevention of COVID-19, NVX-CoV2373 is a recombinant protein